Basics Foghorn Therapeutics Inc. IPO Date: October 23, 2020 Sector: Healthcare Industry: Biotech Market Cap: $228.38M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 4.06% Avg Daily Range (30 D): $0.14 | 3.00% Avg Daily Range (90 D): $0.17 | 3.36% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .1M Trade Size Avg Trade Size (Sh.): 82 Avg Trade Size (Sh.) (30 D): 93 Avg Trade Size (Sh.) (90 D): 85 Institutional Trades Total Inst.Trades: 82 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $.59M Avg Inst. Trade (90 D): $1.54M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.61M Avg Closing Trade (30 D): $.59M Avg Closing Trade (90 D): $1.54M Avg Closing Volume: 219.86K     News Aug 27, 2025 @ 11:00 AM Foghorn Therapeutics to Participate in Three Upcom... Source: Karin Hellsvik Aug 5, 2025 @ 11:00 AM Foghorn Therapeutics Provides Second Quarter 2025 ... Source: Foghorn Therapeutics Inc. May 1, 2025 @ 11:00 AM Foghorn Therapeutics Appoints Neil Gallagher and S... Source: N/A Apr 15, 2025 @ 11:00 AM Foghorn Therapeutics to Host Virtual Investor Even... Source: N/A Oct 1, 2024 @ 11:00 AM Foghorn Therapeutics to Participate in the BMO Onc... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.19 $-.28 $-.3 Diluted EPS $-1.19 $-.28 $-.3 Revenue $ 24.17M $ 7.56M $ 5.95M Gross Profit $ $ $ Net Income / Loss $ -75.4M $ -17.94M $ -18.83M Operating Income / Loss $ -91.87M $ -21.1M $ -22.91M Cost of Revenue $ $ $ Net Cash Flow $ -64.83M $ 13.09M $ 5.57M PE Ratio